- Home
- HST vs ASND Comparison
HST vs ASND Comparison
Compare HST & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HST | ASND |
|---|---|---|
| Founded | 1927 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 13.6B |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HST | ASND |
|---|---|---|
| Price | $18.47 | $225.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 15 |
| Target Price | $18.96 | ★ $278.80 |
| AVG Volume (30 Days) | ★ 8.7M | 713.8K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | ★ 11.11 | N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | ★ $5,387,000,000.00 | N/A |
| Revenue This Year | N/A | $98.02 |
| Revenue Next Year | $1.19 | $43.13 |
| P/E Ratio | $17.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.27 | $124.06 |
| 52 Week High | $21.00 | $248.60 |
Technical Indicators
Market Signals| Indicator | HST | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 38.07 | 46.01 |
| Support Level | $16.99 | $190.49 |
| Resistance Level | $19.01 | $229.94 |
| Average True Range (ATR) | 0.53 | 9.30 |
| MACD | -0.20 | -1.48 |
| Stochastic Oscillator | 0.00 | 21.99 |
Price Performance
Historical ComparisonAbout HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.